Investors / United States / LYFE Capital
LYFE Capital
Venture capital · Menlo Park, CA, United States · North America
LYFE Capital is a healthcare investment platform with five global offices in Asia and the U.S. It invests in healthcare companies and works to scale them into market leaders using its resources and expertise.
Invests inHealthcare & Biotech
In its own wordshealthcarecdmocromedical devicesbiotechsupply chain
Your fit with LYFE Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsLYFE Capital lists 7 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (88%) and Cybersecurity (13%). 67% of its companies are based in United States. It invests most often alongside Lilly Asia Ventures, RA Capital and 1955 Capital.
Counts come from funding rounds that name LYFE Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundLYFE Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 0% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 12th | 7 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 95th | 88% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Lilly Asia Ventures | 2 |
| RA Capital | 2 |
| 1955 Capital | 1 |
| ARCH Venture Partners | 1 |
| B Capital | 1 |
| Elementum VC | 1 |
| Forbion | 1 |
| Frazier Life Sciences | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers686%
- No longer answers00%
- Points to another company114%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 88% | 15% |
| Cybersecurity | 13% | 4% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Lilly Asia Ventures
Compare LYFE Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with LYFE Capital| Date | Company | Stage |
|---|---|---|
| 12 Nov 2026 | Series A | |
| 20 Nov 2025 | Series C+ | |
| 9 Jan 2025 | Series A |
Round details for LYFE Capital
Amounts, full round histories and every co-investor in LYFE Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
7 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aspen Neuroscience develops personalized cell therapies for Parkinson's disease using stem cell biology and genomics | Healthcare & Biotech | Nov 2025Series C+ | Funding round | |
| Bora Pharmaceuticals is a global contract development and manufacturing organization specializing in formulation development, clinical and commercial cGMP manufacturing, and packaging of complex pharmaceutical products | Healthcare & Biotech | Portfolio page | ||
| Brightech builds AI workflows, reliable data platforms, and AWS infrastructure to support healthcare and government operations. | Healthcare & BiotechCybersecurity | Portfolio page | ||
| Fong’s Engineering delivers end-to-end medical device manufacturing solutions through precision engineering and ISO 13485-certified manufacturing. | Healthcare & Biotech | Portfolio page | ||
| Noah Medical develops and sells a system for real-time localization and targeting in medical procedures. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Verdiva Bio is developing next-generation medicines to help people living with obesity, cardiometabolic diseases, and related conditions achieve better health outcomes | Healthcare & Biotech | Jan 2025Series A | Funding round |
About this data
site last read 5 Nov 2026- Site
- lyfecapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 9 Jan 2025
- Companies checked
- 7
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get LYFE Capital's profile as data
Pull LYFE Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/lyfecapital.com
# also
GET /v1/firms/lyfecapital.com/portfolio
GET /v1/firms/lyfecapital.com/coinvestors
GET /v1/firms/lyfecapital.com/news